| NCT01385735 | St. Josef Hospital Bochum | Parkinson Disease | 2011-10 | PHASE4 |
| NCT00696215 | Istanbul University | Parkinson´s Disease | 2007-06 | PHASE4 |
| NCT00104273 | Teva Branded Pharmaceutical Products R&D, Inc.|Eisai Inc. | Dementia|Alzheimer´s Disease | 2004-08 | PHASE2 |
| NCT01382342 | Brown University|Teva Pharmaceuticals USA | Parkinson´s Disease | 2011-06 | PHASE4 |
| NCT01178047 | University of Zurich|H. Lundbeck A+S | Parkinson´s Disease | 2011-09 | PHASE4 |
| NCT01232738 | Yunxia Wang, MD|Western ALS Study Group | Amyotrophic Lateral Sclerosis (ALS) | 2011-12 | PHASE2 |
| NCT00492336 | University of Maryland, Baltimore|Stanley Medical Research Institute | Schizophrenia | 2007-01 | PHASE4 |
| NCT02278588 | State University of New York at Buffalo | Parkinson´s Disease | 2014-11 | |
| NCT01055379 | Lundbeck Italia S.p.A.|Teva Branded Pharmaceutical Products R&D, Inc. | Depressive Symptoms|Parkinson´s Disease | 2010-03 | PHASE4 |
| NCT01497652 | Georgetown University|Teva Neuroscience, Inc. | Parkinson´s Disease | 2012-01 | PHASE4 |
| NCT01879241 | University of Ulm | Amyotrophic Lateral Sclerosis | 2013-06 | PHASE2 |
| NCT01532141 | Bial - Portela C S.A. | Parkinson Disease | 2009-11 | PHASE1 |
| NCT03329508 | Pharma Two B Ltd. | Parkinson Disease|Early Parkinson´s Disease | 2018-01-19 | PHASE3 |
| NCT01155466 | Merck Sharp & Dohme LLC | Parkinson Disease | 2010-07-14 | PHASE3 |
| NCT01736891 | Chongqing Fortune Pharmaceutical Co., Ltd.|Beijing Bionovo Medicine Development Co., Ltd. | Parkinson?s Disease | 2011-11 | PHASE3 |
| NCT01215227 | Merck Sharp & Dohme LLC | Parkinson Disease|Idiopathic Parkinson Disease | 2010-11-18 | PHASE3 |
| NCT02068625 | Insel Gruppe AG, University Hospital Bern | Retinal Detachment | 2010-09 | PHASE4 |
| NCT05611372 | Second Affiliated Hospital, School of Medicine, Zhejiang University|Beijing Tiantan Hospital|Xinhua Hospital, Shanghai Jiao Tong University School of Medicine|Jiangsu Province Nanjing Brain Hospital|The First Affiliated Hospital of Anhui Medical University|Huashan Hospital|Second Affiliated Hospital of Soochow University|Guizhou Medical University|The First Affiliated Hospital of Guangzhou Medical University|West China Hospital|Sir Run Run Shaw Hospital|The Affiliated Hospital of Hangzhou Normal University|The First Affiliated Hospital of Dalian Medical University|Qilu Hospital of Shandong University|Fujian Medical University Union Hospital | REM Sleep Behavior Disorder|Parkinson Disease|Synucleinopathies | 2023-01-01 | PHASE2|PHASE3 |
| NCT00755027 | Fundació Institut de Recerca de l´Hospital de la Santa Creu i Sant Pau | Parkinson´s Disease | 2008-09 | PHASE4 |
| NCT01048229 | Qualissima|H. Lundbeck A+S | Early-stage Parkinson´s Disease | 2008-10 | PHASE4 |
| NCT00977665 | Teva Branded Pharmaceutical Products R&D, Inc.|H. Lundbeck A+S | Multiple System Atrophy | 2009-12 | PHASE2 |
| NCT00399477 | Teva Neuroscience, Inc. | Parkinson´s Disease | 2006-10 | PHASE4 |
| NCT02789020 | University of Florida|National Institute of Neurological Disorders and Stroke (NINDS) | Parkinson´s Disease | 2016-12 | PHASE2 |
| NCT03727139 | Takeda | Parkinson´s Disease | 2018-11-01 | |
| NCT01442610 | Technische Universit?t Dresden|Teva Branded Pharmaceutical Products R&D, Inc. | Sleep Disturbances|Parkinsons´s Disease | 2011-10 | PHASE4 |
| NCT01007630 | The Parkinson´s Institute|Teva Neuroscience, Inc. | Parkinson´s Disease | 2009-11 | PHASE4 |
| NCT00203060 | Teva Neuroscience, Inc. | Parkinson´s Disease | 1997-07 | PHASE3 |
| NCT00203034 | Teva Branded Pharmaceutical Products R&D, Inc. | Parkinson´s Disease | 2000-05 | PHASE3 |
| NCT01968460 | Pharma Two B Ltd. | Parkinson´s Disease | 2013-12 | PHASE2|PHASE3 |
| NCT00256204 | Teva Branded Pharmaceutical Products R&D, Inc. | Parkinson´s Disease | 2005-11 | PHASE3 |
| NCT01652313 | H. Lundbeck A+S | Parkinson´s Disease | 2012-05 | PHASE1 |
| NCT01032486 | Teva Branded Pharmaceutical Products R&D, Inc. | Parkinson´s Disease | 2009-12 | |
| NCT01049984 | Teva Neuroscience, Inc.|H. Lundbeck A+S | Parkinson´s Disease | 2009-12 | PHASE4 |
| NCT01168596 | University of Florida | Parkinson´s Disease | 2009-12 | PHASE4 |
| NCT02359552 | The Cleveland Clinic | Alzheimer´s Disease | 2015-05 | PHASE2 |
| NCT00955604 | Teva Branded Pharmaceutical Products R&D, Inc. | Serotonin Syndrome | 2009-07 | |
| NCT00936676 | Teva Branded Pharmaceutical Products R&D, Inc.|Teva Neuroscience, Inc.|H. Lundbeck A+S | Parkinson´s Disease | 2009-07 | |
| NCT00203138 | Teva Branded Pharmaceutical Products R&D, Inc. | Parkinson´s Disease | 2004-06 | PHASE3 |
| NCT01879748 | Teva Branded Pharmaceutical Products R&D, Inc. | Parkinson´s Disease | 2013-06 | PHASE1 |
| NCT07077187 | New York Medical College | PARKINSON DISEASE (Disorder) | 2014-09-15 | PHASE4 |
| NCT01556165 | H. Lundbeck A+S | Parkinson´s Disease | 2012-04 | PHASE3 |
| NCT01187888 | Prof. Dr. Stefan Lorenzl|Teva Branded Pharmaceutical Products R&D, Inc.|Ludwig-Maximilians - University of Munich | Progressive Supranuclear Palsy | 2010-01 | PHASE3 |
| NCT01155479 | Merck Sharp & Dohme LLC | Parkinson Disease | 2010-07-06 | PHASE3 |
| NCT00203125 | Teva Branded Pharmaceutical Products R&D, Inc. | Parkinson´s Disease | 2000-10 | PHASE3 |
| NCT01723228 | Teva Branded Pharmaceutical Products R&D, Inc. | Parkinson´s Disease | 2012-11 | PHASE4 |
| NCT06798519 | Guangzhou Henovcom Bioscience Co. Ltd. | Parkinson's Disease (PD) | 2025-05-01 | PHASE1 |
| NCT00203164 | Teva Branded Pharmaceutical Products R&D, Inc. | Parkinson´s Disease | 2002-05 | PHASE3 |
| NCT01192503 | University of Virginia|Teva Neuroscience, Inc. | Restless Legs Syndrome | 2010-09 | PHASE2|PHASE3 |
| NCT02337738 | Takeda | Parkinson´s Disease | 2015-01-27 | PHASE2|PHASE3 |
| NCT02337764 | Takeda | Parkinson´s Disease | 2015-02-03 | PHASE3 |
| NCT02337751 | Takeda | Parkinson´s Disease | 2015-07-10 | PHASE3 |
| NCT02337725 | Takeda | Parkinson´s Disease | 2015-02-07 | PHASE3 |